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        MHC-Ia, -Ib, and -I  –  like molecules play a 
critical role in regulating the function of NK 
cells and are recognized by a diverse set of NK 
receptors (  1  ). In humans, MHC-Ia molecules 
are recognized by the NK receptors of the Ig 
superfamily, killer cell Ig-like receptors (KIRs) 
(  2  ) and Ig-like transcript (  3  ), whereas in mice 
they are recognized by structurally divergent 
NK receptors of the C-type lectin superfamily, 
termed Ly49 (  4  ). In contrast to MHC-Ia mole-
cules, NK cell recognition of MHC-Ib and 
MHC-I  –  like molecules is conserved across spe-
cies and mediated predominantly through the 
homodimeric NKG2D (  5  ) and heterodimeric 
CD94-NKG2 receptors (  6  ). 
  Typically NK cell receptors can recognize 
multiple MHC-I and MHC-I  –  like ligands. For 
example, individual KIRs bind multiple MHC-Ia 
allotypes (  7  ). Similarly, members of the Ly49 fam-
ily interact with several distinct MHC-Ia mole-
cules (  8  ), and NKG2D recognizes a diverse array 
of MHC-I –  like ligands, including MICA, MICB, 
and ULBP1-4 in humans, and H60, RAE-1 pro-
teins, and MULT1 in mice (  9  ). Moreover, there 
are also examples of interspecies cross-reactivity 
between mouse NKG2D and the human NKG2D 
ligands (  10  ) that further highlight the evolutionary 
conserved nature of these innate interactions. 
Structural studies on NKG2D, coupled with 
detailed thermodynamic analyses, have provided 
insight into how a single receptor can interact 
with these structurally distinct ligands (  11  –  16  ). 
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  The recognition of human leukocyte antigen (HLA)-E by the heterodimeric CD94-NKG2 
natural killer (NK) receptor family is a central innate mechanism by which NK cells monitor 
the expression of other HLA molecules, yet the structural basis of this highly specifi  c 
interaction is unclear. Here, we describe the crystal structure of CD94-NKG2A in complex 
with HLA-E bound to a peptide derived from the leader sequence of HLA-G. The CD94 
subunit dominated the interaction with HLA-E, whereas the NKG2A subunit was more 
peripheral to the interface. Moreover, the invariant CD94 subunit dominated the peptide-
mediated contacts, albeit with poor surface and chemical complementarity. This unusual 
binding mode was consistent with mutagenesis data at the CD94-NKG2A  –  HLA-E interface. 
There were few conformational changes in either CD94-NKG2A or HLA-E upon ligation, 
and such a   “  lock and key  ”   interaction is typical of innate receptor  –  ligand interactions. 
Nevertheless, the structure also provided insight into how this interaction can be modu-
lated by subtle changes in the peptide ligand or by the pairing of CD94 with other members 
of the NKG2 family. Differences in the docking strategies used by the NKG2D and CD94-
NKG2A receptors provided a basis for understanding the promiscuous nature of ligand 
recognition by NKG2D compared with the fi  delity of the CD94-NKG2 receptors. 726  THE CD94-NKG2A  –  HLA-E COMPLEX | Petrie et al.
the correctness of the molecular replacement solution. In ad-
dition, the electron density at the CD94-NKG2A  –  HLA-
E  VMAPRTLFL   interface was unambiguous, and side chains at 
the interface could be modeled into the electron density 
(Fig. S1, B and C), thus allowing contacts at the interface to 
be interpreted readily. The crystal contained two virtually indis-
tinguishable ternary complexes within the asymmetric unit 
(root mean square deviation 0.7   Å  ). Consequently, struc-
tural analyses will be confi  ned to one CD94-NKG2A  –  HLA-
E  VMAPRTLFL   complex. 
  The CD94-NKG2A docked toward the C-terminal end 
of the HLA-E antigen-binding cleft, binding at an angle of 
    70  °   (  Fig. 1, A and B  , and Figs. S2 and 3, which are avail-
able at http://www.jem.org/cgi/content/full/jem.20072525/
DC1) in a manner that permitted CD94-NKG2A to sit across 
both the     1 and     2 helices of HLA-E (  Fig. 1  ).   A comparison 
of the CD94-NKG2A  –  HLA-E  VMAPRTLFL   complex with the 
  In contrast to the promiscuity of most NK receptors, the 
human CD94-NKG2 family solely recognizes the MHC-Ib 
molecule, HLA-E (  17  –  20  ). The essentially monomorphic 
HLA-E has evolved to selectively bind peptides derived from 
the leader sequences of other class I molecules. Consequently, 
down-regulation of MHC-I expression leads to a reduction 
in HLA-E expression at the cell surface. Accordingly, the 
interaction between CD94-NKG2 and HLA-E represents 
a central innate mechanism by which NK cells indirectly 
monitor the expression of other MHC-I molecules within a 
cell (  17, 18  ). 
  Although it is unclear how the CD94-NKG2 receptor 
family interacts with HLA-E, the association of CD94 with 
NKG2 is critical for the biological activity of this family. Sev-
eral members of the NKG2 family, including NKG2A, -2B, 
-2C, and -2E, dimerize with CD94 in vitro (  21  –  23  ). Mem-
bers of the CD94-NKG2 family diff  er in their affi   nity for 
HLA-E, with the inhibitory CD94-NKG2A binding more 
tightly than CD94-NKG2C; yet the structural basis for this 
observation is unknown (  22, 24  ). To begin to understand the 
mode of CD94-NKG2A interaction with HLA-E, we have 
recently reported the structure of the nonligated CD94-
NKG2A heterodimer, which resolved the preferential pair-
ing of the CD94-NKG2 subunits (  25  ). Mutagenesis studies 
have identifi  ed residues in HLA-E and CD94-NKG2A that 
are critical for the interaction and suggested that each subunit 
made discrete contributions to HLA-E docking (  25  ). 
  Here, we report the structure of the CD94-NKG2A hetero-
dimer in complex with HLA-E bound to a peptide corre-
sponding to residues 3  –  11 of the HLA-G leader sequence. 
Our fi  ndings, together with mutational data, provide a basis 
for understanding the specifi  city of this interaction as well as 
the relative contribution of the CD94 and NKG2A subunits 
in recognizing the monomorphic HLA-E peptide complex. 
    RESULTS   
  Overview of the complex 
  To establish how HLA-E, when bound to the leader se-
quence peptide of HLA-G (residues 3  –  11, VMAPRTLFL, 
HLA-E  VMAPRTLFL  ), was specifi  cally recognized by CD94-
NKG2A, we expressed and purifi  ed both components, crys-
tallized the complex in space group   I4  1  32   with unit cell 
dimensions   a   =   b   =   c   = 345.2   Å  , and determined the struc-
ture of the CD94-NKG2A-HLA-E  VMAPRTLFL   complex to 
3.4   Å   resolution with an   R  factor     and   R  free     of 24.8 and 27.9%, 
respectively (see Materials and methods and   Table I  ).   
Although the CD94-NKG2A  –  HLA-E  VMAPRTLFL   structure was 
determined to moderate resolution, we had previously deter-
mined the structures of the nonligated CD94-NKG2A (  25  ) 
and HLA-E  VMAPRTLFL   molecules (  26  ) to 2.5   Å   resolution that 
enabled the structure to be solved readily by molecular re-
placement, and permitted the ternary complex to be refi  ned 
well at this resolution. For example, the initial experimental 
phases clearly showed unbiased electron density for the 
VMAPRTLFL peptide (Fig. S1 A, available at http://www
.jem.org/cgi/content/full/jem.20072525/DC1), confi  rming 
  Table I.  Data collection and refi  nement statistics 
  Data collection statistics 
Temperature (K) 100
x-ray source NSLS, Beamline X25
Detector ADSC Q315
Space group I4  1  32
Cell dimensions (  Å  ) 345.2, 345.2, 345.2
Resolution (  Å  ) 50.0-3.40
Total no. of observations 680267
No. of unique observations 48105 (6919)
Multiplicity 14.1
Data completeness (%) 100.0 (100.0)
I/      I  16.2 (3.0)
R  PIM   (%) 4.6 (26.5)
Refi  nement statistics
Nonhydrogen atoms
Protein   10174   
Water 0
Resolution (  Å  ) 50   –   3.4
R  factor   (%) 24.8
R  free   (%) 27.9
r.m.s.d from ideality
Bond lengths (  Å  ) 0.007
Bond angles (  °  ) 1.53
Dihedrals 26.59
Impropers 0.963
Ramachandran plot
Most favored 78.2
Allowed 20.0
Generous   1.0   
Unfavored 0.8
B-factors (  Å    2  )   
Average per residue 110
The values in parentheses are for the highest resolution bin (approximate interval 
0.1   Å ).  R PIM   is  R merge   divided by the root square of the redundancy (reference   53  ). 
R  factor   =  100     hkl   |  |F o  | - |F  c  | | /     hkl   |F o  | for all data except for 5%, which was used 
for the R  free   calculation.JEM VOL. 205, March 17, 2008 
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by a large number of polar interactions, including 8 salt 
bridges and 19 H bonds. There was also a small and focused 
patch of hydrophobic contacts at the interface (  Table II  ).   
Somewhat surprisingly, the overall shape complementarity 
(SC) at the interface was relatively poor (SC = 0.63), 
although the SC for CD94 alone was markedly better 
(SC = 0.68) compared with NKG2A (SC = 0.31), which 
further highlighted the greater contribution that CD94 
makes to the docking onto HLA-E  VMAPRTLFL   compared 
with NKG2A. 
  The CD94 footprint on HLA-E was broad, with residues 
within loops 2, 3, and 5, and      strands 6 and 7 from CD94 
interacting with a region spanning residues 65  –  89 from the 
    1 helix of HLA-E (  Fig. 2 C  ). Arg65 of HLA-E is situated at 
the periphery of CD94 subunit and formed van der Waals 
(VDW) interactions with Arg171. Asp69 of HLA-E appeared 
to play a central role in the interaction with CD94, as it salt 
bridged to Arg171 and H bonded to Gln113 (  Fig. 2 C  ). 
Arg75 formed a salt bridge with Asp163 of CD94, whereas 
Arg79 of HLA-E H bonded to Ser143 (  Fig. 2 C  ). Glu89 
from HLA-E, which is located at the loop C-terminal to the 
    1 helix, H bonded to Thr146. Gln72 H bonded to Glu164 
and Asn170 from CD94, whereas the aliphatic moiety of 
Gln72 packed against the aromatic ring of Phe114 (  Fig. 2 C  ). 
Phe114 of CD94 sat in a hydrophobic niche that is formed by 
Ile73 and Val76 from HLA-E and by P8-Phe from the pep-
tide. Moreover, the neighboring Leu162 of CD94, which 
formed VDW contacts with Val76 and packed against the ali-
phatic moiety of Arg75 from HLA-E, extended this hydro-
phobic patch (  Fig. 2 D  ). 
nonligated CD94-NKG2A (  25  ) and HLA-E  VMAPRTLFL   struc-
tures (  26  ) revealed no signifi  cant conformational change in 
either HLA-E or CD94-NKG2A upon complex formation 
(root mean square deviation 0.5 and 0.4   Å   for CD94-NKG2A 
and HLA-E, respectively). The one disordered loop of the 
nonligated CD94-NKG2A heterodimer (residues 199  –  204 in 
NKG2A) became ordered in the complex (not depicted), al-
though this observation was attributable to crystal-packing ef-
fects, as this loop did not contact HLA-E  VMAPRTLFL  . Only one 
residue, Gln 112 of CD94, was re-orientated upon ligation to 
maximize the complementarity at the interface. Accordingly, 
this   “  lock and key  ”   engagement between HLA-E  VMAPRTLFL   
and CD94-NKG2A exemplifi  ed the   “  innate characteristic  ”   
of this interaction. 
  CD94-NKG2A binding to HLA-E 
  The CD94 and NKG2A subunits lay across the antigen-
binding cleft, with CD94 and NKG2A almost exclusively 
interacting with the     1 and     2 helices of HLA-E, respec-
tively. Analysis of the electrostatic surfaces of HLA-E and 
CD94-NKG2A highlighted a role for charge complementa-
rity at the CD94-NKG2A  –  HLA-E interface (  Fig. 2 A  ).   
Namely, a basic region on the     1 helix of HLA-E interacted 
with an acidic region on CD94 and, conversely, an acidic 
region on the HLA-E     2 helix docked with a distinct patch 
of basic charge on NKG2A (  Fig. 2 A  ). The buried surface 
area (BSA) at the interface was extensive (    2,100   Å    2  ), with 
CD94 and NKG2A contributing     69 and 31%, respectively 
(  Fig. 2 B  ). Consistent with the electrostatic complementar-
ity, the CD94-NKG2A  –  HLA-E interface was characterized 
    Figure 1.         The CD94-NKG2A  –  HLA-E  VMAPRTLFL   complex.   NKG2A and CD94 are represented as blue and pale green ribbon structures, respectively. 
The heavy chain of HLA-E and     2m are shown as violet and cyan ribbons, respectively, with the VMAPRTLFL peptide in orange sticks. (A) Side view of 
CD94-NKG2A docking onto HLA-E  VMAPRTLFL  . (B) Top view of CD94-NKG2A docking onto the surface of HLA-E  VMAPRTLFL .   728  THE CD94-NKG2A  –  HLA-E COMPLEX | Petrie et al.
  CD94-NKG2A peptide-mediated contacts 
  Overall, the peptide contributed 23% of the BSA at the 
HLA-E interface, in which the invariant CD94 subunit 
played a much more marked role (80%) in interacting with 
the peptide compared with the NKG2A chain (20%). CD94 
sat over the P8-Phe position of the peptide while NKG2A 
was adjacent to P5-Arg, with its contact being limited to a 
VDW interaction with Pro171 (  Fig. 3, A and B  ).   In contrast, 
CD94 interacted with residues P5-Arg, P6-Thr, and P8-
Phe, with Gln112 intercalated between the bulky P5-Arg 
and P8-Phe and hydrogen bonded to the main chain of 
P6-Thr. Unexpectedly, three polar residues (Asn156, Asn158, 
and Asn160) surrounded and contacted the hydrophobic P8-
Phe, the latter of which also interacted with Phe114 and 
Gln112 (  Fig. 3 B  ). 
  The P5-Arg protruded into a cavity between the NKG2A 
and CD94 subunits (  Fig. 3 A  ), with its aliphatic side chain 
fl  anked in an anti-parallel manner with Gln112 of CD94, 
whereas its guanadinium group H bonded to the main chain 
  When compared with that of CD94, the footprint of 
NKG2A on HLA-E was markedly smaller and more fo-
cused with loop 3 and      strands 2, 5, and 6 interacting 
with residues 151  –  162 of the     2 helix of HLA-E (  Fig. 2 E  ). 
Nevertheless, analogous to the CD94  –  HLA-E interactions, 
the NKG2A  –  HLA-E contacts were dominated by polar 
residues. For example, Asp162 from HLA-E formed a 
salt bridge with Lys217 of NKG2A, whereas Arg137 of 
NKG2A salt bridged to Glu154 and H bonded to Ser151 
of HLA-E. Of the VDW-mediated contacts, the aliphatic 
moiety of Glu154 interacted with Gln212 of NKG2A. 
His155 was nestled between Pro171 and Ser172 of 
NKG2A, and Ala158 interacted with Gln212 and Lys217 
of NKG2A (  Fig. 2 E  ). 
  Accordingly, the large and predominantly polar network 
of interactions between CD94-NKG2A and HLA-E under-
scored the specifi  city of this interaction and highlighted the 
dominant role of the CD94 subunit with respect to the 
NKG2A subunit. 
    Figure 2.         Interaction of CD94-NKG2A subunits to HLA-E  VMAPRTLFL  .   (A) Electrostatics of CD94-NKG2A and HLA-E (represented as surface displaying 
charged regions) reveal charge complementarity that drives the interaction. (B) CD94-NKG2A interaction footprint on HLA-E  VMAPRTLFL  . The surface of HLA-E 
is shown with the peptide as orange space fi  ll. Contacts to HLA-E made by CD94 are represented in pale green, and those made by NKG2A are in blue. 
Both subunits contact P5-Arg and are shown in teal. (C) Key interactions of CD94 to HLA-E     1 helix. Hydrogen bonds are formed between Gln113 to 
Asp69 of HLA-E, which also forms a salt bridge with Arg171 of CD94. Asn170 and Glu164 both form hydrogen bonds with Gln72 of HLA-E, whereas 
Glu89 forms a hydrogen bond with Thr146. (D) Binding of CD94 to HLA-E involves hydrophobic interactions between CD94 Phe114 and Leu162 by Ile73 
and Val76 of HLA-E and P8-Phe of the peptide. Leu162 is also involved in VDW interactions further along the     1 helix. In addition, neighboring Asp163 
forms a salt bridge with Arg75 of HLA-E, and Ser143 of CD94 forms a hydrogen bond with Arg79. (E) Key NKG2A interactions with HLA-E    2  helix. 
Arg137 forms a hydrogen bond with Ser151 and a salt bridge with Glu154 of HLA-E. His155 of HLA-E forms a hydrogen bond with Ser172 while making 
VDW contacts with Pro171. Ala158 of HLA-E makes VDW contacts with Gln212 and Lys217 of NKG2A, the latter of which forms a salt bridge with Asp162 
and the     2 helix. Hydrogen bonds are represented as black dashed lines, and salt bridges are in blue.      JEM VOL. 205, March 17, 2008 
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of Ser110 of CD94 (  Fig. 3 B  ). However, the P5-Arg did not 
appear to be well complemented by any charged interactions 
with the CD94-NKG2A, which may be attributable to it salt 
bridging to Glu152 of HLA-E. 
  Accordingly, the interactions with the peptide are domi-
nated by the invariant CD94 subunit, in which the major 
determinants of the peptide, namely positions P5 and P8, appear 
poorly matched in terms of the chemical and electrostatic 
complementarity to CD94-NKG2A. 
  Verifi  cation of the footprint 
  Before determining the structure of the CD94-NKG2A  –
  HLA-E ternary complex, we conducted an alanine-scanning 
mutagenesis and surface plasmon resonance study at this in-
terface (  25  ). Accordingly, this not only provided us with an 
opportunity to independently verify the structural footprint 
from the low-resolution structure reported here, but it also 
allowed us to address the energetic basis of this specifi  c inter-
action. First, of the 16 mutations that were made in HLA-E, 
8 residues were shown to be important in the interaction. 
All of these HLA-E residues (Arg65, Arg75, Arg79, Val76, 
Gln72, Glu152, Asp162, and Glu166), which encompassed 
residues from the     1 and     2 helices, made contacts with 
CD94-NKG2A in the ternary complex (  Fig. 4 A  ). Second, 
of the 21 alanine-scanning mutations made in CD94-
NKG2A, 10 residues were shown to be important for the in-
teraction. Again, the structural data indicated that these 
CD94-NKG2A residues (CD94: Gln112, Phe114, Asn160, 
Leu162, Asp163, Glu164, Asp168; NKG2A: Gln212, Arg137, 
Arg215) made contacts with HLA-E, thereby further con-
fi   rming the interpretation of the CD94-NKG2A  –  HLA-E 
  Table II.  CD94-NKG2A contacts with HLA-E and VMAPRTLFL 
peptide 
HLA-E contacts
NKG2A HLA-E TYPE
Arg137  NH1  Ser151  O     H bond
Arg137  NH2  Glu154  O    1  Salt bridge
Arg137 Ser151 VDW
Arg137 Glu154 VDW
Lys164 Arg65 VDW
Pro171 His155 VDW
Ser172 His155 VDW
Lys199  N  	  Asp162  O  
  2  Salt bridge
Lys199 Asp162 VDW
Gln212 Ala158 VDW
Gln212 Glu154 VDW
Val213 His155 VDW
Lys217 Asp162 VDW
Lys217  N  	    Asp162  O  
  2  H bond
Lys217 Ala158 VDW
Ser223 Arg131 VDW
Ser224 Arg131 VDW
CD94 HLA   –  E
Ser77  O     Arg65  NH2 H  bond
Ser77 Arg65 VDW
Gln112 Ile73 VDW
Gln112  N    2 Glu152  O    2  H bond
Gln113 Arg65 VDW
Gln113  O    1 Asp69  O  
   H bond
Gln113 Asp69 VDW
Phe114 Gln72 VDW
Phe114 Val76 VDW
Ser143  O     Arg79  NH2 H  bond
Ser143 Arg79 VDW
Thr146 Glu89 VDW
Thr146  O    1 Glu89  O    1  H bond
Phe147 Arg79 VDW
Asn160 Val76 VDW
Asn160 Arg79 VDW
Asn160  O  
  1  Arg79  NH1 H  bond
Asn160  ° Arg79  NH2 H  bond
Ala161 Val76 VDW
Ala161  ° Arg79  NH2 H  bond
Ala161 Arg79 VDW
Leu162 Gln72 VDW
Leu162 Arg75 VDW
Leu162 Val76 VDW
Asp163  O  
  1  Arg75  NH2 Salt  bridge
Asp163 Arg75 VDW
Glu164 Glu19 VDW
Glu164  O    1 Gln72  N    2  H bond
Glu164 Gln72 VDW
Glu168  O  
  2 Glu19  O    2  H bond
Asn170 Gln72 VDW
  Table II.  CD94-NKG2A contacts with HLA-E and VMAPRTLFL 
peptide (Continued) 
HLA-E contacts
Arg171 Arg65 VDW
Arg171  NH1 Arg65  NH2 H  bond
Arg171  NH2  Asp69  O  
  2  Salt bridge
PEPTIDE CONTACTS
NKG2A PEPTIDE
Pro171 Arg  5 VDW
CD94 PEPTIDE
Ser110 Arg5 VDW
Ser110  ° Arg5  NH2 H  bond
Gln112 Arg5 VDW
Gln112 Thr6 VDW
Gln112  N    2  Thr6  ° H  bond
Gln112  O    1  Thr6  N H  bond
Gln112 Phe8 VDW
Phe114 Phe8 VDW
Asn156 Phe8 VDW
Asn158 Phe8 VDW
Asn160 Phe8 VDW
  Superscripts refer to atomic nomenclature. 730  THE CD94-NKG2A  –  HLA-E COMPLEX | Petrie et al.
alanine-scanning mutations and included charge-reversal 
mutations (Asp69 to Arg; Glu154 to Arg), which enabled the 
specifi  city of the interaction to be further addressed.   Only 
one mutation (Glu152 Val) had a signifi  cant eff  ect on the af-
fi  nity of the interaction, which highlighted that it is the nega-
tive charge of Glu152, and not the aliphatic moiety per se, 
that is a requisite for this interaction. The charge-reversal 
mutations had no eff  ect on the affi   nity of the interaction, 
consistent with the corresponding alanine-scanning muta-
tions at these positions, thereby further confi  rming that posi-
tions 69 and 154 are not critical for determining the specifi  city 
of the interaction. Position 155 represents a polymorphic site 
between HLA-E (His155) and other HLA-Ia molecules 
(Gln155); surprisingly, substitution of His155 to Gln or Ser 
had a diff  erential eff  ect, with the former having a moderate 
eff  ect on the affi   nity of the interaction, whereas the latter had 
no signifi  cant impact. Moreover, positions 65, 69, and 155, 
which make contacts with the TCR in all TCR  –  MHC-I 
structures determined to date (  27, 28  ), all appear to be dis-
pensable in the interaction with CD94-NKG2A (  Fig. 4 C  ), 
further highlighting the diff  ering requirements for adaptive 
and innate receptors interacting with MHC molecules. 
  Comparison to other footprints 
  The structure of the CD94-NKG2A  –  HLA-E  VMAPRTLFL   com-
plex provided an opportunity to compare it to (a) the 
        TCR  –  HLA-E  VMAPRTLIL   complex (  Fig. 3 C   and Figs. S2 
and S3) (  29  ), thereby allowing us to address how both innate 
and adaptive receptors can recognize the same ligand, and (b) 
the homodimeric NKG2D  –  MHC-like ligand complexes (  11, 
12, 14  ), which enabled us to address the central issue of pro-
miscuous versus specifi  c NK receptor recognition. First, the 
position of the CD94-NKG2A footprint on HLA-E  VMAPRTLFL   
was similar to the footprint of an HLA-E  –  restricted TCR 
(termed KK50.4; Figs. S2 and S3) (  29  ). Similar to CD94-
NKG2A, the KK50.4 TCR formed an extensive footprint on 
HLA-E  VMAPRTLIL  , focusing on the C-terminal end of the anti-
gen-binding cleft with the TCR docked in a diagonal mode; 
however, in contrast to CD94-NKG2A recognition of HLA-E, 
each chain of the         TCR contributed roughly equally to the 
interface (Figs. S2 and S3). The KK50.4 TCR interacted pre-
dominantly with positions P5-Arg and P8-Ile of the peptide, 
analogous to that of CD94-NKG2A, suggesting that both in-
nate and adaptive receptors are sensitive to changes to posi-
tions P5 and P8 of the peptide. Nevertheless, although the 
interactions between the peptide and CD94-NKG2A were 
CD94 centric, both chains of the TCR made substantial con-
tacts with the peptide, with the TCR     chain focused on the 
peptide positions P4-P6, and the TCR     chain interacting 
with P8-Ile (  Fig. 3 C  ). Notably, the interactions between the 
        TCR and the peptide exhibited excellent chemical com-
plementarity, which contrasted markedly with the CD94 
peptide-mediated interactions (  Fig. 3 C  ). 
  Second, the location of the CD94-NKG2A footprint on 
HLA-E  VMAPRTLFL   was analogous to the positioning of the 
footprint of human NKG2D on its MHC-like ligands, MICA 
footprint (  Fig. 4 B  ). Nevertheless, as expected, there were 
residues that made contact at the interface that did not con-
tribute signifi  cantly to the energetics of the interaction as as-
sessed by surface plasmon resonance (see Discussion). 
  To further assess the footprint of CD94-NKG2A on 
HLA-E, an additional nine mutations were made in HLA-E, 
and the impact of these mutations was examined using sur-
face plasmon resonance. These mutations (  Fig. 4 C  ) were not 
    Figure 3.         Peptide-mediated contacts to CD94-NKG2A.   (A) The sur-
face of CD94 (pale green) clearly accommodates Arg5 and Phe8 of the 
peptide (orange sticks) presented on HLA-E (violet ribbon). NKG2A (blue 
surface) makes minimal contact with the peptide. (B) Pro171 is the only 
residue of NKG2A that interacts with the peptide, at P5-Arg. CD94 domi-
nates recognition of the peptide making several interactions, including 
hydrogen bonds of Ser110 to P5-Arg and Gln112 to P6-Thr. A distinct 
polar pocket created by Asn156, Asn158, Asn160, and Phe114 on CD94 
accommodates P8-Phe. (C) KK50.4 TCR interactions to HLA-E  –  presenting 
peptide VMAPRTLIL. Interactions are dominated by the V     chain of the 
TCR in a manner analogous to CD94-NKG2A interactions.     JEM VOL. 205, March 17, 2008 
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MHC-like ligands (  Fig. 5 A  ) (  11, 12, 14  ). Moreover, the 
closer juxtapositioning of the     1 and     2 helices of MICA 
and ULBP3 enabled each NKG2D subunit within the homo-
dimer to interact with both      helices to some extent, 
whereas the interactions with the CD94 and NKG2A sub-
units are virtually polarized to each      helix of HLA-E (  Table II  ). 
Moreover, although CD94-NKG2A is structurally homo-
logous to NKG2D, diff  erent regions within these NK receptors 
were used to interact with their respective ligands (  Fig. 5 C  ). 
In contrast to the predominantly electrostatic nature of the 
CD94-NKG2A  –  HLA-E  VMAPRTLFL   interaction, the polar inter-
actions contribute to but do not dominate the interaction 
between NKG2D and its ligands (  Fig. 5, B and C  ). Specifi  -
cally, the nonpolar interactions at the NKG2D-MHC  –  like 
and CD94-NKG2A  –  HLA-E  VMAPRTLFL   interfaces contribute 
    60 and 40% to the BSA at the interface, respectively. This 
diff  erential usage of polar-mediated contacts may account for 
the promiscuity in NKG2D recognition compared with a high 
degree of specifi  city for ligand displayed by CD94-NKG2A. 
  Accordingly, the innate NK receptors and the         TCR 
focus on a similar region of the HLA-E or MHC-like ligand, 
regardless of whether the ligand presents peptide or not. 
However, the characteristics of the footprint deviate between 
these receptors, thereby providing a basis for the NKG2D 
promiscuity versus the CD94-NKG2A specifi  city. 
    DISCUSSION   
  We have determined the structure of the CD94-NKG2A  –
  HLA-E  VMAPRTLFL   complex and thereby provide a structural 
basis for the specifi  city of this interaction, which contrasted 
with the promiscuous recognition of MHC-like ligands 
by the homodimeric NKG2D receptor. There was little 
evidence of conformational adjustments of either CD94-
NKG2A or HLA-E  VMAPRTLFL   in the formation of the 
CD94-NKG2A  –  HLA-E  VMAPRTLFL   complex, which is consis-
tent with previous thermodynamic measurements that sug-
gested a   “  rigid body  ”   mode of recognition (  22  ). This lock 
and key interaction contrasts with the conformational plastic-
ity that is exemplifi  ed by antigen recognition by the adaptive 
immune system (  30  ). Although CD94 and NKG2A are struc-
turally similar, the distribution of surface electrostatics of 
CD94-NKG2A diff  ered markedly, dictating the docking ori-
entation of these subunits on HLA-E. A surprising feature of 
the CD94-NKG2A  –  HLA-E  VMAPRTLFL   complex was the de-
gree to which CD94 dominated the interaction with HLA-E 
and the peptide, as NKG2A was limited to contacting a small 
region on the     2 helix of HLA-E and a single VDW contact 
with the peptide. 
  Our previous alanine-scanning mutagenesis data that 
assessed the energetic contribution of HLA-E and CD94-
NKG2A residues at the interface validated our observed 
positioning of CD94-NKG2A on HLA-E  VMAPRTLFL   (  25  ). 
Virtually all of the HLA-E residues that were critically impor-
tant to the affi   nity of the interaction interacted with CD94-
NKG2A and vice versa. The role of Glu152 from HLA-E 
remains unclear because although this residue directly interacted 
and, to a lesser extent, ULBP3 (  Fig. 5, A and B  ).   Neverthe-
less, there were notable diff  erences between these footprints, 
which are attributable to the narrower cleft between the 
     helices of MICA and ULBP3 compared with HLA-E, 
and the structural diff  erences between CD94-NKG2A and 
NKG2D. CD94-NKG2A possessed a fl  at interacting surface 
with HLA-E, whereas that of NKG2D was more   “  saddle-
like,  ”   which enabled it to clamp around both      helices of the 
    Figure 4.         Energetically important residues and the corresponding 
structural footprint.   (A) Surface representation of HLA-E with bound 
peptide (orange). (B) Surface representation of CD94-NKG2A, with CD94 
colored green and NKG2A colored blue. Residues that have been shown, 
via mutagenesis, to infl  uence binding (moderate and signifi  cant effects) 
are shown in yellow. Residues that make contacts but have no demon-
strable effect on the affi  nity of binding are shown in gray. (C) Relative 
binding of HLA-E mutants to CD94-NKG2A. The binding affi  nity of each 
mutant was determined by surface plasmon resonance, and the relative 
effect on binding was compared with wild-type (WT) HLA-E, which was 
normalized to a value of 1. There was no effect on binding if there was a 
less than threefold difference in binding affi  nity, whereas a greater than 
eightfold difference represented a signifi  cant effect.     732  THE CD94-NKG2A  –  HLA-E COMPLEX | Petrie et al.
  Despite the dominant role of CD94, paradoxically 
there is an approximate sixfold diff  erence in the affi   nity of 
CD94-NKG2A (0.7   μ  M) versus CD94-NKG2C (4.4   μ  M) 
for HLA-E  VMAPRTLFL   (  22, 24  ). The structure of the CD94-
NKG2A  –  HLA-E  VMAPRTLFL   complex allowed us to begin 
to address the basis of this observation. Surprisingly, of the 
sequence diff  erences between NKG2A and NKG2C, none 
directly contacts HLA-E  VMAPRTLFL  . However, a region of 
NKG2A-2C sequence diff  erence spans residues 166  –  170, 
which lies at the interface of the CD94-NKG2A heterodimer 
and has been shown to modulate the affi   nity for HLA-E (  26  ). 
This region is in close vicinity to the P5-Arg binding pocket, 
and accordingly it is conceivable that alterations in the hetero-
dimer interface may impact on the affi   nity of the interaction. 
Because none of the residues that was exchanged directly 
contacts HLA-E, it is also possible that these diff  erences are 
indirect, namely impacting on the conformation of proximal 
residues in CD94. 
  The interactions made by CD94-NKG2A with the HLA-
E  –  bound peptide were suboptimal in chemical, shape, and 
with Gln112 of CD94, the Glu152 Ala and Glu152 Val muta-
tions may also aff  ect the conformation of P5-Arg, which is a 
critical determinant for CD94-NKG2A recognition (  31  ). 
Other HLA-E residues that contacted CD94-NKG2A either 
had a moderate role (Arg65, Arg79, and Glu166) in the ener-
getics interaction or no role at all (Asp69 and Glu154). The al-
anine-scanning mutagenesis also revealed that CD94 played a 
notably more dominant role in the energetics of the inter-
action compared with the NKG2A subunit. Specifi  cally, the 
CD94 energetic hotspot comprised residues Gln112, Phe114, 
Asn160, Leu162, Asp163, and Glu164, all of which interacted 
with HLA-E or the peptide, whereas surprisingly no NKG2A 
residues were identifi  ed as being critical to the interaction. 
Collectively, these observations also reveal that the energetic 
footprint of the CD94-NKG2A  –  HLA-E  VMAPRTLFL   interaction 
is smaller than the corresponding structural footprint. Such an 
observation is consistent with that observed in adaptive im-
munity (  32, 33  ) and contrasts the more synonymous structural 
and energetic footprints of the innate NKT TCR –  CD1d inter-
action (  34, 35  ). 
    Figure 5.         Comparison of polar versus nonpolar interactions by CD94-NKG2A and NKG2D homodimer.   Nonpolar interactions are represented in 
purple, and polar interactions are in blue. In situations where a residue makes both nonpolar interactions as well either a salt bridge or hydrogen bond, it 
was represented as making a polar interaction. (A) Ribbon representation of CD94-NKG2A in complex with HLA-E  VMAPRTLFL   and NKG2D homodimers bind-
ing to MICA and ULBP3. The subunit of the NKG2D homodimer equivalent to CD94 is represented in pale green, and the subunit equivalent to NKG2A is 
in blue. The MHC-like molecules, MICA and ULBP3, do not associated with     2m (represented in cyan), and these molecules are represented in violet. 
(B)   “  Polarity  ”   footprints onto MHC molecules HLA-E by CD94-NKG2A, and MICA and ULPB3 by NKG2D homodimer. The peptide presented by HLA-E is 
represented in orange space fi  ll. (C) Residues of CD94-NKG2A and the NKG2D homodimer involved in polar and nonpolar interactions.     JEM VOL. 205, March 17, 2008 
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that their footprints were broadly similar. Nevertheless, the 
molecular basis for ligand recognition diff  ered dramatically 
with CD94-NKG2A recognition of HLA-E being domi-
nated by charged interactions, whereas hydrophobic inter-
actions played a more signifi  cant role in ligand recognition by 
NKG2D. This dependence on charge in the CD94-NKG2A –
  HLA-E interaction bears notable similarity with the inter-
action between KIRs and their class I ligands where disruption 
of salt bridges abrogated recognition of HLA-C (  46, 47  ). 
  Although the evolutionary origins of the CD94-NKG2 
receptors are not entirely clear, comparison of CD94 and 
NKG2 sequences in primates and rodents further empha-
sized the importance of CD94. Although there is signifi  cant 
cross-species variation in the residues that correspond to 
those in NKG2A that contact HLA-E, 5 of the 13 CD94 
residues that contact HLA-E are completely conserved across 
both primates and rodent species (  48  –  52  ). Thus, although 
CD94 by itself is unable to bind HLA-E, it nevertheless dic-
tates the specifi  city of the interaction, whereas the primary 
role of the NKG2 subunit is to determine the outcome of 
ligand recognition. 
  MATERIALS AND METHODS 
  Protein expression and purifi  cation of CD94-NKG2A and HLA-E.   
  HLA-E was expressed as inclusion bodies in   Escherichia coli   and refolded 
with the VMAPRTLFL peptide according to the previously described 
method (  29  ). The refolded HLA-E  VMARPTLFL   complex was further purifi  ed 
using anion exchange and gel fi  ltration chromatography. The extracellular 
domains of CD94 and NKG2A (CD94 residues 52  –  179, NKG2A residues 
110  –  223) were expressed as inclusion bodies in   E. coli   and refolded as de-
scribed previously (  25  ). The refolded CD94-NKG2A heterodimer was puri-
fi  ed by anion exchange and gel fi  ltration chromatography, followed by an 
additional purifi  cation step using anion exchange. The CD94-NKG2A  –
  HLA-E  VMARPTLFL   complex was generated by mixing the CD94-NKG2A 
heterodimer with HLA-E  VMARPTLFL   at a molar ratio of 1.2:1, respectively. 
The complex was purifi  ed via size exclusion chromatography for use in 
crystallization. The mutagenesis and surface plasmon resonance  –  based ex-
periments were conducted as described previously (  25  ). 
  Crystallization, data collection, structure determination, and refi  ne-
ment.     Large crystals (  >  0.3 mm) of CD94-NKG2A  –  HLA-E  VMARPTLFL   com-
plex were grown at 5 mg/ml in 2.0 M NH  4  SO  4  , 0.1 M Tris-HCl, pH 
7.7  –  7.9. Drops were made at a ratio of 2:1 (1   μ  l protein/0.5   μ  l mother liquor) 
via the hanging drop vapor diff  usion method, and crystals were grown at 
18  °  C. Crystals were fl  ash frozen at 100 K using 20% glycerol as a cyroprotec-
tant. A 3.4   Å   dataset was collected at the X25 beamline (Brookhaven) using 
an ADSC Q315 detector. The data were processed and scaled using the 
CCP4 suite. The crystals belong to space group   I4  1  32  , with   a   =   b   =   c   = 345.2   Å  , 
with two complexes per asymmetric unit, with a high solvent content of 80%. 
Although the crystals diff  racted only to 3.4   Å   resolution, the I/      I   in the high-
est resolution bin (3.5  –  3.4     Å  )   was   3.0,   and the overall R  PIM   (  53  ) value to this 
resolution was 4.6%. Attempts to dehydrate the crystals or to fi  nd an alter-
native crystallization condition failed to yield better diff  racting crystals. The 
crystal structure of the complex was solved by molecular replacement imple-
mented by Phaser (  54  ) using CD94-NKG2A and HLA-E (minus the bound 
peptide) as the search models. First, we used CD94-NKG2A (PDB code: 
3bdw) as a search model and readily located two molecules within the asym-
metric unit. We then fi  xed this initial solution and searched for the corre-
sponding HLA-E molecules in which the peptide had been deleted (PDB 
code: 3bze) (unpublished data). Again, two HLA-E molecules were located 
within the asymmetric unit, with the HLA-E molecules sitting   “  beneath  ”   the 
electrostatic complementarity, in that the P8-Phe and the 
P5-Arg are accommodated within a polar and a noncharged 
pocket, respectively. Nevertheless, CD94-NKG2A recogni-
tion is sensitive to substitutions at both P5 and P8 positions of 
the peptide (  25, 31  ). For example, P8-Tyr abrogated recogni-
tion, which may be attributed to unfavorable interactions 
with Phe114 of CD94, and substituting the P8 position to 
smaller residues, such as P8-Leu, Val, and Ala, also reduced 
the affi   nity of the interaction, presumably by creating a cavity 
at the interface. Similarly, the conservative P5-Arg to P5-Lys 
mutation abrogated recognition, suggesting either that the 
P5-Lys-Glu 152 salt bridge is lost, thereby introducing a bur-
ied positive charge at the interface, or highlighting the im-
portance of the P5 residue interacting with the main chain of 
Ser110. Nevertheless, this lack of complementarity is atypical 
in innate receptor  –  ligand interactions and is perhaps more 
characteristic of the   “  imperfect  ”   interfaces that have been ob-
served in adaptive immunity (  27  ). 
  Several proteins other than MHC-I molecules have also 
been shown to encode peptides that can bind to HLA-E. Per-
haps the best characterized of these is encoded by UL40 pro-
tein of CMV that contains VMAPRTLIL, an exact mimic of 
a sequence found in most HLA-C alleles, and both binding 
and functional studies have demonstrated an interaction with 
CD94-NKG2A (  24, 26, 36, 37  ). Based on the structure of 
the CD94-NKG2A  –  HLA-E  VMAPRTLFL   complex, the presence 
of an Ile rather than a Phe at P8 would not be predicted to 
improve the chemical or SC around P8. Consistent with this, 
binding data indicate that the substitution of Ile for Phe re-
sults in a threefold reduction in the affi   nity of the interaction. 
In addition, peptides derived from HCV core antigen (YLL-
PRRGPRL) (  38  ), the ATP-binding cassette transporter 
multi  drug resistance  –  associated protein 7 (ALALVRMLI) (  39  ), 
and gliadin (SQQPYLQLQ) (  40  ) have also been shown to 
bind HLA-E and protect otherwise susceptible target cells via 
a CD94-NKG2  –  dependent mechanism. Given the marked 
diff   erences of these peptides from the canonical MHC-I 
leader sequence peptide, it will be of interest to establish 
how these peptides, when bound to HLA-E, interact with 
CD94-NKG2A. 
  In addition to being a ligand for the CD94-NKG2 recep-
tors, HLA-E is recognized by CD8 T cells expressing con-
ventional         TCRs (  41  –  44  ). The data presented here reveal 
that the footprint of CD94-NKG2A on HLA-E closely over-
laps with that of an HLA-E  –  restricted TCR (KK50.4) (  29  ). 
Interestingly CD94-NKG2 receptors are also expressed on 
these HLA-E  –  specifi  c T cells (unpublished data) (  45  ). Given 
the diff  ering affi   nities between the TCR and CD94-NKG2 
receptors for HLA-E, it will be of interest to dissect the bio-
logical outcome with these cells. In vitro data suggests that 
expression of the cognate ligand of the HLA-E  –  restricted 
TCR can result in T cell activation despite the expression of 
the inhibitory CD94-NKG2A receptor (  45  ). 
  Given the sequence and structural conservation between 
CD94-NKG2A and NKG2D, as well as their ligands HLA-
E, MICA, MICB, and ULBP1-4, it is perhaps not surprising 734  THE CD94-NKG2A  –  HLA-E COMPLEX | Petrie et al.
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CD94-NKG2A solutions, indicating that we had located two ternary com-
plexes in the asymmetric unit. Searching for a third ternary complex failed to 
yield a solution. To verify that the molecular replacement solution was correct, 
a   2 F  o  -F  c     electron density map was calculated and revealed unbiased electron 
density for the omitted peptide chain. The progress of refi  nement was moni-
tored by the   R  free     value (5% of the data) with neither a      nor a low-resolution 
cutoff   being applied to the data, and no water molecules were modeled in the 
structure. The structure was refi   ned using Phenix (  55  ) interspersed with 
rounds of model building in   “  Coot  ”   (  56  ). Given the limited resolution of the 
data, the refi  nement proceeded cautiously, with tight noncrystallographic 
restraints applied to the independent copies within the asymmetric unit. 
Refi  nement of B factors led to an     4% drop in the   R  factor     and   R  free     values, thereby 
justifying the refi  nement of this parameter. As such, the complex refi  ned very 
well, presumably aided by the fact that we had previously determined the 
structures of the nonligated NKG2A and HLA-E components to a 2.5   Å   reso-
lution; moreover, there were few conformational changes that took place 
upon complexation. For the data collection and refi  nement statistics, see   
Table I  . See Fig. S1 for quality of electron density. All BSA calculations were 
undertaken using MSD PISA (http://www.ebi.ac.uk/msd-srv/prot_int/
pistart.html). The PDB of the CD94-NKG2A  –  HLA-E complex has been 
deposited in the RCSB protein data bank, and the coordinate accession code 
is 3CDG. 
  Online supplemental material.     Fig. S1 shows regions of unbiased 
and fi  nal electron density for the complex. Fig. S2 shows a comparison 
of structural footprints, and Fig. S3 shows the docking mode of CD94-
NKG2A and other receptors. Figs. S1  –  S3 are available at http://www.jem
.org/cgi/content/full/jem.20072525/DC1. 
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